Guide to Clinical Evaluation: The State-of-the-Art (SOTA) Literature Review

Dr Will Brambley

Under the EU MDR, the importance of a robust and well-structured state-of-the-art (SOTA) literature review cannot be overstated. It serves as the foundation of the clinical evaluation process, offering regulators and stakeholders a clear, evidence-based understanding of where a device fits within its clinical context.

In this third episode of our Guide to Clinical Evaluation video series, we explore an overview of the SOTA literature review including its purpose and overall structure. We guide you through its essential components, demystifying the process and explaining how it supports clinical evaluation. You’ll learn how to:

  • Place your device in clinical context by outlining the conditions it addresses, its intended use, and how it achieves therapeutic benefit.
  • Assess the performance and safety of SOTA devices to understand current clinical expectations and identify relevant comparators.
  • Develop safety and performance objectives that define measurable benchmarks for evaluation within the Clinical Evaluation Plan (CEP) and Clinical Evaluation Report (CER).

We’ll also share our structured approach to conducting these reviews, from defining the clinical background and search strategy to appraising literature and synthesizing data into actionable insights.

A Proven Framework for Success

At Mantra Systems, we know what success looks like. Our approach to clinical evaluation is built on experience: over 300 successful evaluations conducted under MDR. This track record reflects not just regulatory knowledge, but also a deep commitment to patient safety, clinical relevance, and quality of evidence.

Through this series, we’ll share that expertise with you, helping you avoid the pitfalls we see most often and giving you a clear pathway to stronger, more resilient submissions.

Subscribe to our newsletter to keep up with the full five-part series on mastering MDR clinical evaluation, including:

  1. What is clinical evaluation?
  2. Clinical evaluation in context
  3. The State-of-the-Art (SOTA) review – core of a successful submission
  4. The CEP and CER
  5. Clinical evaluation pitfalls and useful resources

Related articles

  1. US and EU flag signposts pointing in different directions

    Top 5 mistakes US manufacturers make when entering the EU market

    Expanding into the EU market? Discover the five most common regulatory mistakes U.S. medical device manufacturers make — and how to avoid them.

    Aastha Kothari Aastha Kothari Regulatory Medical Writer
  2. A process flow leading to a cybersecurity evidence pack

    EU MDR, FDA 510(k) and DTAC Cybersecurity Nonconformities: How to Recover

    This guest article shows how these cybersecurity nonconformities happen, what recovery actually involves, and what to build so you don't go back.

    Neil Richardson Neil Richardson Co-Founder of Cyber Alchemy
  3. Turning blocks from crosses to ticks

    How to handle non-conformities and get back on track

    A practical guide to understanding why non-conformities happen, the most common issues in medical device submissions, and how to resolve them efficiently to get you back on track.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  4. US and EU flags on poles alongside each other.

    Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance

    FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  5. 3 people in an office in front of a whiteboard with the words 'Medical Device Market Entry Strategy' written above a world map.

    EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry

    This guest article shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.

    Luke Hill Luke Hill Co-Founder of Cyber Alchemy
  6. An illustration showing a GPS-driven navigation route superimposed upon someone using a laptop.

    Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US

    All three markets operate under different regulatory systems and place different demands on manufacturers.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  7. A woman uses an inhaler.

    Navigating EU MDR Article 117: A Practical Guide to Drug-Device Combination Product Submissions

    Implementation of the EU MDR 2017/745 has brought significant changes.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  8. NHS CEP logo.

    Mantra Systems becomes an official Programme Partner of the NHS Clinical Entrepreneur Programme

    We're proud to join a this initiative supporting healthcare workers and patients to develop innovative solutions for the NHS.

    Paul Hercock Paul Hercock CEO & Founder
  9. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    EU MDR and FDA post-market obligations aren't as similar as you might think. Here's what manufacturers need to know.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  10. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  11. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  12. An illustration showing a business woman pole-vaulting across a ravine.

    Eliminating the Top 5 Notified Body Gaps in Clinical Evaluation Through Pre-Submission Review

    From insufficient clinical evidence to Post-Market issues - we guide you past common NB deficiencies.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP